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Abstract The vascular endothelium response to ischemic 
depletion of ATP was studied in vitro. Endothelial cells (EC) 
cultured from human aorta or umbilical vein were incubated in a 
glucose-free medium containing CCCP or rotenone. Such 
blockade of energy metabolism caused a drop in ATP, 
destruction of actin filaments, morphological changes, and 
eventually disintegration of EC monolayer within 2-2.5 h. While 
ATP fell and F-actin collapsed, the 27-kDa heat shock protein 
(Hsp27) lost basal phosphorylation and became Triton X-100- 
insoluble forming granules inside the cell nuclei. Protein 
phosphatase (PP) inhibitors (okadaic acid, cantharidin, sodium 
orthovanadate) did not delay the ATP decrease in energy- 
deprived EC but arrested both the alterations in the Hsp27 status 
and the changes for the worse in F-actin and cell morphology. 
Similarly, the Hsp27 dephosphorylation/insolubilization/granula- 
tion and the cytoskeletal and morphological disturbances 
resulting from lack of ATP were suppressed in heat-precondi- 
tioned (thermotolerant) cultures, this effect being sensitive to 
quercetin, a blocker of Hsp induction. The longer preservation of 
the cytosolic pool of phosphorylated Hsp27 during ATP 
depletion in the PP inhibitor-treated or thermotolerant EC 
correlated with the acquired resistance of F-actin and morphol- 
ogy. These data suggest that PP inhibitors as well as heat- 
inducible Hsp(s) can protect ischemia-stressed cells by preventing 
the ATP loss-provoked protein dephosphorylation and break- 
down of the actin cytoskeleton. 
© 1998 Federation of European Biochemical Societies. 
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1. Introduction 
A severe fall of cellular ATP is one of the most detrimental 
consequences of ischemia or anoxia that deranges the cyto- 
skeleton and its interactions with the plasma membrane, thus 
dramatically affecting cell morphology and viability (see for 
review [1,2]). Organization of microfilaments and their con- 
tacts with the plasma membrane are mainly regulated by pro- 
tein kinases and protein phosphatases (PP) via phosphoryla- 
tion/dephosphorylation f actin-associated and regulatory 
proteins [1,3]. Depletion of ATP in cells during ischemia or 
anoxia may shift the balance between phosphorylation and 
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dephosphorylation toward the latter, since all kinase reactions 
require ATP. Indeed, anoxia in rabbit proximal renal tubules 
completely suppressed protein phosphorylation, whereas pro- 
tein dephosphorylation was unchanged or enhanced [4]. Such 
abnormal prevalence of protein dephosphorylation ver phos- 
.phorylation was suggested as a probable cause of the cyto- 
skeletal collapse under ischemia or anoxia [1,4-6]. In support 
of this suggestion, dephosphorylation f two actin-regulating 
proteins, ezrin in anoxic rabbit proximal renal tubules [5] and 
the 27-kDa heat shock protein (Hsp27) in ATP-depleted hu- 
man endothelial cells (EC) [6], was shown to occur and, in 
both cases, this was accompanied by disorganization f micro- 
filaments. 
At the same time, an increase in intracellular Hsp(s) ap- 
pears to allow ATP-deprived cells to longer preserve intact 
F-actin, normal morphology and viability [2,7 10]. Despite 
the obvious importance of this phenomenon nothing is known 
about its molecular basis. It was discussed that direct Hsp- 
actin binding may protect microfilaments from fragmentation 
and aggregation during ATP depletion [2,11] but there is no 
evidence in favor of such a mechanism. Now we speculate 
about an ability of excess Hsp(s) somehow to attenuate the 
protein dephosphorylation in ATP depleted cells that is crit- 
ical for the state of the actin cytoskeleton. To examine this we 
have focused our studies on Hsp27. The main in vivo func- 
tions of this protein are actin reorganization i response to 
cell-activating stimuli [12,13] and protection of F-actin under 
stresses [14-18]. In cells overexpressing Hsp27, the actin net- 
works were more resistant to heating [14,15], oxidants [16,17] 
and cytochalasin D [14,18] that was associated with improved 
survival of the treated cells. The protective potential of human 
Hsp27 toward microfilaments i  up-regulated by phosphoryl- 
ation of its serine residues Ser 15, Ser 7s and Ser ~2 in a stress- 
and mitogen-sensitive signaling pathway [15 18]. In contrast, 
non-phosphorylated Hsp27 is able to inhibit actin polymer- 
ization [12,13,19]. Moreover, phosphorylation/dephosphoryla- 
tion of Hsp27 can alter its ofigomeric structure, solubility and 
localization in cells thereby influencing its functional (actin- 
regulating) activity [6,15,19,20]. Thus, if one explores how the 
ATP loss-enhanced protein dephosphorylation affects the mi- 
crofilament stability, Hsp27 seems to be a suitable object for 
monitoring. 
In our last report [6], we showed that sustained ATP deple- 
tion in human vascular EC reduces basal phosphorylation of
Hsp27; simultaneously, Hsp27 becomes Triton-insoluble and 
forms granules inside the cell nuclei. Under such conditions, 
endothelial microfilaments break and aggregate that results in 
loss of normal morphology and barrier properties of EC 
monolayer [21 -24]. As we discussed above, the F-actin dis- 
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ruption in ATP-deprived cells may be connected with the 
stress-provoked dephosphorylat ion f the microfi lament con- 
stituents and accessory proteins (e.g. ezrin, Hsp27 and others). 
To prevent protein dephosphorylat ion under ATP depletion 
we used PP inhibitors sodium orthovanadate,  okadaic acid 
and cantharidin, two latter being known to block Hsp27 de- 
phosphorylat ion i vivo [20,25]. In parallel, we elevated the 
Hsp content in EC by heat precondit ioning; herein we looked 
for development of the cytoskeletal tolerance to lack of ATP 
as it was demonstrated for other cells [7-10]. The main goal of 
the present work was to reveal the expected relation between 
the Hsp27 phosphorylat ion, the F-actin stability, and the level 
of Hsp expression in the context of ATP depletion. 
2. Materials and methods 
2.1. Cells, A TP depletion and A TP determination 
EC were isolated from human aortas or umbilical veins and cul- 
tured according to described technique [26]. The confluent cell cul- 
tures of the 1 3 passages were taken for the experiments. 
The cellular ATP stores were depleted by incubating the cells in 
glucose-free Dulbecco's modified Eagle's minimal essential medium 
(Sigma) containing 3% fetal bovine serum and supplemented with 
20 p-M carbonyl cyanide m-chlorophenylhydrazone (CCCP, a mito- 
chondrial uncoupler) or 20 I.tM rotenone (a respiratory chain inhib- 
itor) [6]. Cellular ATP was extracted and then measured by luciferin/ 
luciferase method using ATP assay kit (Calbiochem) [6,8]. 
2.2. Tolerance-inducing treatments 
To block in vivo protein phosphatase activity 1 ~tM okadaic acid 
(Calbiochern) or 0.2 ~tM cantharidin (Sigma), or 100 laM sodium 
orthovanadate (Aldrich) were added immediately in the incubation 
medium for all period of the ATP-depleting stress. 
Thermotolerance d veloped after heating EC cultures in a thermo- 
static water bath at 45°C for 10 min followed by recovery at 37°C 
during 14-18 h. Cytoresistance to elevated temperature and to ATP 
depletion was tested using fluorescence and phase-contrast micros- 
copy. Stability of the F-actin structures and preservation of normal 
EC morphology during 30 rain heating (45°C) or 2 h ATP depletion 
were considered characteristic signs of the acquired tolerance. 
2.3. Celljractionation with Triton X-IO0 
Growing in plastic 35 mm dishes confluent EC were lysed with 0.3 
ml of ice-cold phosphate buffered saline (PBS, pH 7.4) containing 1% 
(w/v) Triton X-100, 3 mM ethylenediaminetetraacetic acid and inhib- 
itors of proteolysis (30 lag/ml of leupeptin and 1 mM phenylmethyl- 
sulfonyl fluoride). The cell lysates were promptly centrifuged at 
12000×g for 10 min at 4°C, and the pellets were then washed with 
the lysing buffer and resedimented. The first supernatants (Triton- 
soluble cellular fraction) and the washed pellets (Triton-insoluble c l- 
lular fraction) were prepared as samples for Laemmli electrophoresis 
[6]. 
2.4. Fluorescence staining 
EC adherent to gelatin-covered coverslips were fixed and permea- 
bilized with a mixture of 3.7% formaldehyde/0.1% Triton X-100 for 10 
rain. Thereafter the preparations were washed trice with PBS and 
incubated with 1% bovine serum albumin tbr 30 min to decrease a
non-specific staining. In situ F-actin and Hsp27 were labeled with 
phalloidin-TRITC conjugates (Sigma) and anti-Hsp27 rabbit antibod- 
ies (kindly provided by Dr. M. Gaestel [27]) as previously described 
[6]. The stained samples were viewed and photographed on an Opton 
llI microscope (Karl Zeiss, Germany). 
2.5. Electrophoresis, immunoblotting and isoelectric focusing 
Total EC or cellular fractions were dissolved in a reducing sample 
buffer with the inhibitors of proteolysis, boiled for 5 min, and run by 
electrophoresis in Laemmli system with 4% stacking and 12.5% sepa- 
rating polyacrylamide gels. For Western blotting, separated proteins 
were electrotransferred from the gel slabs onto nitrocellulose mem- 
brane (0.45 Ixm, Bio-Rad). Hsp27 and inducible Hsp70 (Hsp70i) were 
detected using rabbit anti-Hsp27 antibodies [27] and monoclonal anti- 
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body C92F3A-5 specific for Hsp70i (StressGen) followed by labeling 
with anti-rabbit IgG and anti-mouse IgG-peroxidase conjugates, re- 
spectively. Images of the antigen bands developed on X-ray film 
(Amersham) by means of the enhanced chemiluminescence (ECL) 
method [6]. 
For isoelectric focusing (IEF), confluent EC in 60 mm dishes were 
lysed into 8 M urea supplemented with 5%, [3-mercaptoethanol, 2%
Nonidet P-40, and 100 ~M sodium orthovanadate. Aliquots of the 
lysates were loaded in tubes with 5% polyacrylamide gel containing 8
M urea, 2% Nonidet P-40, and 2% ampholines (LKB, pH 5-7) and 
exposed to 500 V overnight and then to 1000 V for 1 h. Electro- 
transfer of proteins from the gel rods onto nitrocellulose was per- 
formed according to Zhou et al. [28]. HSP27 isoforms were detected 
by immunoblotting with anti-HSP27 antibodies and ECL as described 
above. 
3. Results 
3.1. PP inhibitors attenuate ffects of  ATP  depletion on Hsp27, 
F-actin and EC morphology 
Here we demonstrate how cell-permeant PP inhibitors 
ameliorate the EC responses to energy deprivation. The fol- 
lowing reagents were tested: (i) sodium orthovanadate mainly 
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Fig. l. PP inhibitors and acquired thermotolerance suppress Hsp27 
dephosphorylation i  ATP-depleted EC. Each horizontal row of 
spots represents a Hsp27 isoform spectrum in sample aliquots from 
equal numbers of cells (3× 105) which were separated by IEF and 
blotted using ECL. A: Isoforms of Hsp27 in control (non-tolerant) 
cells without stress (1) and after ATP depletion as a result of 2 h 
incubation in glucose-free medium containing 20 ~M CCCP (2). B: 
Inhibitory effects of 1 [aM okadaic acid (1) and 0.2 ~tM cantharidin 
(2) on Hsp27 dephosphorylation in cells subjected to 2 h ATP de- 
pletion as in A. The same effect as with okadaic acid and canthari- 
din was achieved with 100 laM sodium orthovananadate (not pre- 
sented). C: Hsp27 isoforms in thermotolerant (preheated) cells 
without stress (1) and after 2 h ATP-depleting exposure as in A (2). 
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blocking tyrosine PP, (ii) okadaic acid, which inhibits serine/ 
threonine PP1 and PP2A with the stronger effect toward the 
latter, and (iii) cantharidin, a fairly specific blocker of PP2A 
in vivo [25]. None of these inhibitors retarded the ATP loss in 
cells treated with CCCP or rotenone (Kabakov and Gabai, 
unpublished ata). At the same time, all the EC responses to 
ATP depletion described in [6] were markedly attenuated in 
the presence of 100 ~M sodium orthovanadate or 1 IuM oka- 
daic acid, or 0.2 ~tM cantharidin (all the concentrations were 
chosen as non-toxic for human EC). Each of these treatments 
inhibited both the dephosphorylation/redistribution, of Hsp27 
and the F-actin collapse and the deterioration of morphology 
in ATP-deprived EC cultures (Figs. 14). 
In vivo human Hsp27 can comprise up to four isotbrms 
corresponding to non-phosphorylated (a), monophosphoryl- 
ated (b), biphosphorylated (c), and triphosphorylated ( ) 
Hsp27 (see Fig. l and [6,15]). 2 h ATP depletion dramatically 
decreased the share of all the three phospho-isoforms and 
augmented the non-phosphorylated a isoform (Fig. 1A), 
whereas the PP inhibitors uppressed this shift in the isoform 
spectrum (Fig, 1B) thus indicating inhibition of the Hsp27 
dephosphorylation. Being mostly localized to Triton-soluble 
fraction of unstressed EC Hsp27 is insolubilized uring ATP 
depletion (Fig. 2A and [6]). This ATP loss-induced Hsp27 
insolubilization slowed down by sodium orthovanadate, can- 
tharidin (both not shown) and okadaic acid (Fig. 2B). With- 
out stress, immunofluorescent patterns of endothelial Hsp27 
display diffuse distribution in the cytoplasm and the nucleus, 
and sometimes cytoplasmic aggregates; when ATP falls, the 
Hsp27-containing granules how up inside all the cell nuclei 
(see Fig. 3A,C and [6]). Okadaic acid (Fig. 3E) as well as two 
other inhibitors used (not shown) suppressed intranuclear 
granulation of Hsp27 in ATP-depleted EC. 
The attenuation of the Hsp27 dephosphorylation/insolubi- 
lization/granulation in EC losing ATP in the presence of ei- 
ther sodium orthovanadate or cantharidin, or okadaic acid 
seems to correlate with the cytoresistance. Cultured EC con- 
tain many straight F-actin bundles (so called stress fibers) 
(Fig. 3B) which are disrupted after 2 h ATP depletion (Fig. 
3D), Contrary to that, the preexisting stress fibers are pre- 
served within ATP-depleted EC if the incubation medium 
contained sodium orthovanadate or cantharidin (both not 
shown), or okadaic acid (Fig. 3F). The cobblestone structure 
intrinsic to an intact EC monolayer (Fig. 4A) breaks follow- 
ing the cytoskeletal collapse in ATP-deprived EC and, after 2 
h ATP depletion, detachment of the damaged cells begins 
(Fig. 4B). Under the same conditions, the PP inhibitor-treated 
EC exhibit good morphology and the cell detachment is ab- 
sent (Fig. 4C). Apparently, the PP inhibitors contribute to 
stabilization of the actin framework upon blockade of energy 
metabolism thus enabling ATP-depleted EC somewhat to re- 
tain correct shape, intercellular contacts and monolayer integ- 
rity. 
3.2. Heat preconditioning confers EC tolerance to A TP 
depletion 
Mild heat shock (45°C, 10 rain) in cultured EC with sub- 
sequent recovery at 37°C during 12-18 h induced Hsp accu- 
mulation (Fig. 5) and thermoresistance. The latter was man- 
ifested in the improved state of the cytoskeleton and the 
integrity of cell monolayer after severe heat shock (45°C, 30 
rain) as compared with non-tolerant EC (not shown). Simul- 
taneously, the preheated cells became resistant o the sus- 
tained (2 2.5 h) ATP-depleting stress, although the rate of 
the ATP decrease in them was not slower than that in the 
non-preheated cells. Intact thermotolerant EC had F-actin 
patterns unaltered relative to non-tolerant EC (see Fig. 3B). 
Being devoid of ATP, the thermotolerant cells preserved both 
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Triton-soluble Hsp27 
Triton-insoluble Hsp27 
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Effect of Okadaic Acid 
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Fig. 2. PP inhibitors and acquired thermotolerance maintain soluble pool of Hsp27 in ATP-depleted EC. ECL blots show Hsp27 bands in sam- 
ple aliquots of Triton X-100-soluble and -insoluble fractions obtained from equal numbers of cells (3x 105). A: (1) unstressed non-tolerant 
cells; (24) 0.5 h, 1 h and 2 h incubation with 20 raM CCCP without glucose (ATP depletion). B: (1) unstressed cells; (24) 0.5 h, t h and 2 h 
ATP depletion as in A but in the presence of 1 ~M okadaic acid. The same effects as with okadaic acid were achieved with 0.2 I.tM cantharidin 
and 100 ~uM sodium orthovananadate (both not presented). C: (1) unstressed thermotolerant cells; (24) time points of ATP-depleting exposure 
as in A. 
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Fig. 3. Effects of PP inhibitors and acquired thermotolerance on distribution of Hsp27 and F-actin in ATP-depleted EC. A, B: Unstressed cells 
exhibiting usual distribution of Hsp27 (A) and intact F-actin fibers (B). C, D: Intranuclear granulation of Hsp27 (C) and F-actin disruption 
(D) after 2 h ATP depletion in non-tolerant cells. E, F: Prevention of intranuclear granulation of Hsp27 (E) and F-actin protection (F) during 
2 h ATP depletion in the presence of 1 laM okadaic acid. The same results as with okadaic acid were observed with 0.2 ~tM cantharidin and 
100 ~M sodium orthovananadate (not presented). G, H: Suppression of intranuclear granulation of Hsp27 (G) and stability of F-actin fibers 
(H) after 2 h ATP depletion in thermotolerant cells. (Magnification x 400.) 
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Fig. 4. Protective ffects of PP inhibitors and acquired thermotolerance on morphology of ATP-depleted EC. A: Unstressed confluent culture 
exhibiting characteristic cobblestone structure. B: Deterioration of morphology and disintegration f monolayer resulting from 2 h ATP deple- 
tion (glucose deprivation+20 laM CCCP) in non-tolerant culture. C: Morphological tolerance of EC culture after 2 h ATP depletion as in B 
but in the presence of 1 gM okadaic acid. The same protective ffects as with okadaic acid were observed with 0.2 laM cantharidin and 100 
laM sodium orthovananadate (not presented). D: Improved preservation f morphology and integrity of cell monolayer in thermotolerant EC
culture undergoing 2 h ATP depletion as in B. (Magnification x 100.) 
the F-actin fibers (Fig. 3H) and normal morphology (Fig. 4D) 
for a long period (2-2.5 h). No cell detachment was found in 
the thermotolerant cultures after 3 h ATP deprivation. The 
acquired cytoresistance to ATP depletion finished in 25-30 h 
after heat shock; this was accompanied by loss of thermotol- 
erance, decay of Hsp70i and diminution of the Hsp27 content 
to the initial level. 
Like the PP inhibitors used, the heat shock-induced ther- 
motolerance attenuated the Hsp27 reactions to depletion of 
ATP. Marked impairment of the ATP loss-provoked Hsp27 
dephosphorylation was revealed in the samples of thermo- 
tolerant EC (Fig. 1C). Despite the increase in a total amount 
of endogenous Hsp27 after the heat pretreatment (Fig. 5), the 
Hsp27 insolubility during ATP depletion was less in thermo- 
tolerant EC than in the control cells (Fig. 2A,C). No Hsp27- 
containing ranules were seen in nuclei of thermotolerant EC
after 2 h ATP deprivation (Fig. 3G). Such an arrest of the 
Hsp27 dephosphorylation/insolubilization/granulation in 
ATP-depleted EC took place only in time limits of the ac- 
quired thermotolerance and correlated with the transient in- 
crease in Hsp expression. Thus, prior heat shock as well as the 
PP inhibitors provides a way to avoid the alterations in both 
Hsp27 and F-actin which result from ATP depletion. The 
microfilament resistance to lack of ATP appears to define 
the better preservation of the cell shape, cell-cell and cell-ma- 
trix contacts, and, as a consequence, the integrity of cell 
monolayer in thermotolerant EC cultures undergoing energy 
starvation. 
To examine whether the effects observed in the thermo- 
tolerant cells depend on the Hsp accumulation, we added to 
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Fig. 5. Heat shock-induced accumulation of Hsp70i and Hsp27 in 
thermotolerant EC and inhibitory effect of quercetin. ECL blots 
demonstrate he antigen bands in sample aliquots from equal num- 
bers of cells (3× 105). (1) Non-tolerant cells; (2) ceils rendered ther- 
motolerant after heat shock (45°C, 10 min) and 14 h recovery at 
37°C in growth medium; (3) cells preheated as in (2) and then incu- 
bated with 30 gM quercetin (Serva) for the first 6 h of post-heat 
shock recovery. 
heat-shocked EC 30 [aM quercetin, which blocks the heat 
shock gene transcription [29] and thereby abolishes cytopro- 
tection mediated by inducible Hsps [30]. Fig. 5 shows that 
quercetin prevented the Hsp accumulation after heat shock. 
Furthermore, this reagent wholly abolished in preheated EC 
both the development of thermoresistance and the attenuation 
of the ATP drop-evoked changes in the Hsp27 status. All the 
beneficial effects of heat preconditioning on F-actin and mor- 
phology of ATP-depleted EC were also nullified by quercetin. 
This suggests that the post-heat shock EC adaptation to en- 
ergy deprivation including stabilization of microfilaments and 
longer preservation of Hsp27 in the initial (phosphorylated 
and soluble) state is mediated by accumulation of heat-in- 
ducible Hsp(s). 
4. Discussion 
In the present work, we have shown that the PP inhibitors 
and the heat pretreatment exert similar effects on ATP-de- 
pleted EC, namely (i) arrest of the Hsp27 dephosphoryla- 
tion/insolubilization/granulation, (ii) protection of F-actin 
from fragmentation and aggregation, and (iii) preservation 
of normal morphology and integrity of cell monolayer. We 
think all these effects are interrelated. No doubt, the increased 
stability of the cytoskeleton in the PP inhibitor-treated or
thermotolerant EC determines their morphological tolerance 
to the ATP-depleting stress. With regard to Hsp27, the inhib- 
ition of its dephosphorylation upon ATP depletion is suffi- 
cient to abolish the insolubilization and intranuclear granula- 
tion (see Figs. 2B and 3E); however, it is yet unknown 
whether this event alone is sufficient for the cytoprotection 
observed. Retardation in dephosphophorylation of other cel- 
lular proteins (if it occurs) may also be significant for blocking 
the cytoskeletal nd morphological perturbations in ATP-de- 
prived EC. It was reported in 1992 that two inhibitors of PPI 
and PP2A, calyculin A and okadaic acid, not preventing the 
ATP drop reduced the osmotic fragility and death of ische- 
mia-stressed rat myocytes [31]. In our model, inhibition of 
PP1 by okadaic acid may be beneficial for endothelial F-actin, 
since increased activity of PP1 has been shown to bring about 
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the dephosphorylation f myosin light chain and the disas- 
sembly of microfilaments in non-muscle cells [32]. PP2A, a 
major target for okadaic acid and cantharidin, appears to 
be responsible for the dephosphorylation f Hsp27 in vivo 
[25]. On the one hand, the discovered arrest of the Hsp27 
dephosphorylation during ATP depletion may be a particular 
case of a wider phenomenon (i.e. the reduced ephosphoryla- 
tion of many proteins) that somewhat ensures cytoprotection 
under energy deprivation. On the other hand, the artificial 
maintenance of the cytosolic (soluble) pool of phosphorylated 
Hsp27 within ATP-depleted EC may by itself contribute to 
the microfilament stability. In support of the latter, phos- 
phorylated Hsp27 only was shown to be involved in protec- 
tion of F-actin under heat shock [14,15], oxidative stress 
[16,17], and treatment with cytochalasin D [14,18], whereas 
non-phosphorylated Hsp27 promotes the reduction of F-actin 
in cells [12,13]. The precise mechanism of the protective action 
of sodium orthovanadate on ATP-depleted EC is unclear. 
Being an inhibitor of tyrosine PP this reagent may exert multi- 
ple effects on different cellular systems including the cytoskel- 
eton. In our model, the suppression of the Hsp27 dephos- 
phorylation by sodium orthovanadate appears to be due to 
the inhibition of a tyrosine PP involved in down-regulation f
PPZA [33]. 
It is well known that non-lethal heat shock induces in mam- 
malian cells the Hsp-mediated resistance to ATP depletion or 
ischemia, or anoxia (reviewed in [2]), though the machinery of 
this cross-tolerance r mains to be clarified. Probably, tolerant 
cells enriched by Hsp70i can maintain the integrity of the 
cytoskeleton during ATP depletion [7-10] but no apparent 
ties between Hsp70 and microfilaments were revealed in 
ATP-deprived EC [2]. Nonetheless, the blocking action of 
quercetin indicates that the revealed effects of heat precondi- 
tioning on both Hsp27 and F-actin, and morphology of ATP- 
depleted EC are mediated by stress-inducible Hsp(s). Besides 
Hsp70i, prior heat shock increased the intracellular coritent of 
other Hsps including Hsp27 (Fig. 5). Martin et al. [34] have 
demonstrated that a rise in endogenous Hsp27 alone improves 
survival of rat cardiomyocytes undergoing simulated ischemia. 
However, it is poorly understood why excess Hsp27 within 
thermotolerant EC less undergoes the ATP drop-associated 
modifications (see Figs. 1 3). Speculating about the Hsp- 
mediated resistance of the cytoskeleton to lack of ATP we 
suggest that Hsp70i and/or other inducible Hsps can somehow 
block protein dephosphorylation during ATP depletion. In 
other words, inducible Hsps simulate the action of PP inhib- 
itors that protects F-actin in case of energy deprivation. While 
mechanisms of the Hsp-mediated antiischemic defence are still 
a mystery, the suggested ability of excess Hsp(s) to neutralize 
the unbalanced PP activity within ATP-depleted cells seems to 
be quite an attractive idea. 
In conclusion, we would like to note a medical aspect of our 
study. In vivo, depletion of cellular ATP can take place under 
acute ischemia and in case of surgical operations connected 
with bypass perfusion or transplantation of organs. The F- 
actin collapse within ATP-deprived EC leads to dysfunction 
of the endothelial barrier that aggravates ischemic lesions 
[23,24]. Evidently, EC tolerance to lack of ATP should im- 
prove outcome of an ischemic onset as well as recovery after 
'surgical stress'. Our results allow us to point out two poten- 
tial ways for protection of ATP-depleted EC: (i) usage of cell- 
permeant PP inhibitors and (ii) heat preconditioning to ele- 
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vate the intracellular Hsp content. The former seems to be a 
basis for creation of novel antiischemic drugs. In turn, the 
latter may find a use as the adapting pretreatment of isolated 
donor organs which are intended for implantation. 
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